OEC signs fluoroscope deal with Genzyme:
This article was originally published in Clinica
Executive Summary
Genzyme of Cambridge, Massachusetts, and OEC Medical Systems of Salt Lake City, Utah, have reached an agreement for OEC to supply its Series 9600 cardiac mobile fluoroscope systems to Genzyme's cardiovascular units. At the same time the companies will now co-market their respective technologies in minimally-invasive cardiovascular surgery, through combined sales and training materials.